South and Central America Microplate Reader Market Forecast


New York, May 25, 2021 (GLOBE NEWSWIRE) – Reportlinker.com Announces the Publication of the “South and Central America Microplate Reader Market Forecast to 2027 – Impact of COVID-19 and Regional Analysis by Type, Application and end user “- https://www.reportlinker.com/p06075785/?utm_source=GNW
However, the high cost of the advanced microplate reader is the major factor hampering the growth of the market.

A microplate reader is a laboratory machine used to estimate biochemical or physical reactions, properties, and analytes in the microplate well.It reduces operational time to save reagent costs, allowing researchers to spend more time to analyze data and create actionable insights.

Pharmaceutical R&D is gaining popularity around the world due to the increasing focus on drug discovery. The American biopharmaceutical industry has been the world leader in the development of new therapies.

According to Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical industry invested $ 83 billion in R&D in 2019. Growing demand for new approaches in drug discovery is driving the growth of microplate readers.

Various companies are developing microplate readers for the drug discovery process to make the research process easier and faster. Additionally, pharmaceutical companies are investing heavily in drug discovery, gene sequencing, and targeted protein development to meet growing demand from the healthcare industry. In addition, the development of personalized medicine is leading to an increasing demand for genetic studies which, in turn, is likely to contribute to the growth of the microplate reader market.

The coronavirus outbreak has adversely affected the region of South and Central America, and at present, the majority of diagnostic laboratories and research institutes are engaged in the diagnosis of COVID-19 patients.

In addition, the COVID-19 diagnostic testing industry is experiencing an upsurge due to an increasing number of cases coupled with increasing emergency use authorizations from regulatory agencies. In addition, several diagnostic companies are engaged in the development of COVID-19 rapid point-of-care diagnostic tests having higher sensitivity and reduced turnaround time, limiting the market for microplate readers in America. South and Central America.

Based on Type, the South and Central America microplate reader market is segmented into Single-Mode Microplate Readers and Multi-Mode Microplate Readers. Single-mode microplate reader segment held larger market share in 2019, while multi-mode microplate reader segment is expected to register higher CAGR in the market during the forecast period.

On the basis of application, the South and Central America microplate reader market is segmented into genomics and proteomics research, drug discovery, clinical diagnostics, and others. The drug discovery segment held the largest share of the market in 2019, while the clinical diagnostics segment is expected to register the highest CAGR in the market during the forecast period.

Based on the end user, the South and Central America microplate reader market is segmented into hospital and diagnostic laboratories, biotechnology and pharmaceutical companies, and research institutes and academics. The biotech and pharmaceutical companies segment held the largest share of the market in 2019, and the same segment is expected to register the highest CAGR of the market during the forecast period.

Some of the primary and secondary sources associated with this South and Central America Microplate Reader market report are the Centers for Disease Control and Prevention (CDC), National Health Service (NHS), and Pharmaceutical Research and Manufacturers of America (PhRMA ).
Read the full report: https://www.reportlinker.com/p06075785/?utm_source=GNW

About Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________



About Hector Hedgepeth

Check Also

Oxford BioDynamics Checkpoint Inhibitor Response Test (EpiSwitch® CiRT) Now Available in the UK

Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for …

Leave a Reply

Your email address will not be published.